Literature DB >> 11853654

Biological Warfare: Implications for Antimicrobial Use.

Ethan Rubinstein1, Itzhak Levi.   

Abstract

Biological warfare is intended to incapacitate a large number of individuals at a single exposure, creating epidemic-type disease, death, and social chaos. The organisms with potential for immediate use as bacteriologic weapons are Bacillus anthracis, Brucella melitensis, Yersinia pestis, and Vibrio cholera, all necessitating antibiotic therapy for a cure. It is reasonable, therefore, to assume that a biological attack, or even a hoax, would requiure thousands of individuals over a large area to begin antibiotic therapy. Issues such as antibiotic availability, logistical problems in antibiotic distribution, development of drug resistance, side effects influencing the individual, and adverse effects on the community due to the impact of mass therapy on the ecology, make biological warfare the most apocalyptic scenario for the creation of a "postantibiotic era."

Entities:  

Year:  2002        PMID: 11853654     DOI: 10.1007/s11908-002-0064-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  23 in total

1.  In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.

Authors:  C H Choe; S S Bouhaouala; I Brook; T B Elliot; G B Knudson
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Antimicrobial susceptibility of Bacillus anthracis.

Authors:  M Doğanay; N Aydin
Journal:  Scand J Infect Dis       Date:  1991

Review 3.  Doxycycline revisited.

Authors:  N Joshi; D Q Miller
Journal:  Arch Intern Med       Date:  1997-07-14

4.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Authors:  M Galimand; A Guiyoule; G Gerbaud; B Rasoamanana; S Chanteau; E Carniel; P Courvalin
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

5.  Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.

Authors:  P Russell; S M Eley; D L Bell; R J Manchee; R W Titball
Journal:  J Antimicrob Chemother       Date:  1996-04       Impact factor: 5.790

6.  Chemical and biological weapons: the hazard to health.

Authors: 
Journal:  WHO Chron       Date:  1970-03

7.  From asps to allegations: biological warfare in history.

Authors:  A G Robertson; L J Robertson
Journal:  Mil Med       Date:  1995-08       Impact factor: 1.437

8.  [Virulence of rifampicin and quinolone resistant mutants of strains of plague microbe with Fra+ and Fra- phenotypes].

Authors:  I V Ryzhko; A I Shcherbaniuk; E D Samokhodkina; R I Tsuraeva; B N Mishn'kin; I V Kasatkina; T A Zhigalova
Journal:  Antibiot Khimioter       Date:  1994-04

Review 9.  Development of novel vaccines against anthrax in man.

Authors:  A V Stepanov; L I Marinin; A P Pomerantsev; N A Staritsin
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

Review 10.  The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

Authors:  A F Kaufmann; M I Meltzer; G P Schmid
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.